27 related articles for article (PubMed ID: 26112080)
1. Case analysis of hepatotoxicity caused by vancomycin.
Wu J; Zhou Y
J Med Case Rep; 2024 Jun; 18(1):267. PubMed ID: 38831463
[TBL] [Abstract][Full Text] [Related]
2. The Association Between Dimethylacetamide Exposure and Liver Toxicity: A Large Retrospective Analysis in Workers From Four European Factories.
Antoniou EE; Gelbke HP; Ballach J; Zeegers MP; Schrage A
J Occup Environ Med; 2021 Dec; 63(12):e893-e898. PubMed ID: 34608893
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.
Yang Z; Chen D; Zhang J; Yao D; Gao K; Wang H; Liu C; Yu J; Li L
Gynecol Oncol; 2016 May; 141(2):231-239. PubMed ID: 26115978
[TBL] [Abstract][Full Text] [Related]
4. Finding a Direct Method for a Dynamic Process: The DD (Direct and Dynamic) Cell-Tox Method.
Madorran E; Kocbek Šaherl L; Rakuša M; Takač I; Munda M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791172
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Hepatotoxic Effects of Fluoropyrimidine Chemotherapy in Male Iraqi Colorectal Cancer Patients.
Challoob MA; Mohammed NS
Cureus; 2024 Apr; 16(4):e58126. PubMed ID: 38741871
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for irinotecan-induced liver injury: a retrospective multicentre cross-sectional study in China.
Han J; Liu J; Yu Z; Huang R; Zhao L; Xu Y; Chen M; He G; Song Q; Li W; Zhang C
BMJ Open; 2023 Jun; 13(6):e069794. PubMed ID: 37349101
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the Possible Protective Effect of
Gençosman S; Ceylanlı D; Şehirli AÖ; Teralı K; Bölükbaşı F; Çetinel Ş; Sayıner S
Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36421407
[TBL] [Abstract][Full Text] [Related]
8. A Biobank of Colorectal Cancer Patient-Derived Xenografts.
Abdirahman SM; Christie M; Preaudet A; Burstroem MCU; Mouradov D; Lee B; Sieber OM; Putoczki TL
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825052
[TBL] [Abstract][Full Text] [Related]
9. The incidence and risk factors of hepatotoxicity induced by perioperative hyperthermic intraperitoneal chemotherapy in gastrointestinal carcinoma patients: a retrospective study.
Zheng Z; Yu H; Xiong B; Shen S; Yang H; Zhou Y
Onco Targets Ther; 2018; 11():5715-5722. PubMed ID: 30254464
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function.
Gong J; Cho M; Fakih M
J Gastrointest Oncol; 2017 Apr; 8(2):314-323. PubMed ID: 28480070
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
Peeters M; Price TJ; Cervantes A; Sobrero AF; Ducreux M; Hotko Y; André T; Chan E; Lordick F; Punt CJ; Strickland AH; Wilson G; Ciuleanu TE; Roman L; Van Cutsem E; Tzekova V; Collins S; Oliner KS; Rong A; Gansert J
J Clin Oncol; 2010 Nov; 28(31):4706-13. PubMed ID: 20921462
[TBL] [Abstract][Full Text] [Related]
12. FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study.
Kochi M; Akiyama Y; Aoki T; Hagiwara K; Takahashi T; Hironaka K; Teranishi F; Osuka F; Takeuchi M; Fujii M; Nakajima T
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1097-102. PubMed ID: 24057041
[TBL] [Abstract][Full Text] [Related]
13. Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer.
Teufel A; Steinmann S; Siebler J; Zanke C; Hohl H; Adami B; Schroeder M; Klein O; Höhler T; Galle PR; Heike M; Moehler M
BMC Cancer; 2004 Jul; 4():38. PubMed ID: 15265233
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of metastatic colorectal cancer.
Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
[TBL] [Abstract][Full Text] [Related]
15. Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience.
Vincenzi B; Imperatori M; Picardi A; Vespasiani Gentilucci U; Gallo P; Fausti V; Spalato Ceruso M; Santini D; Tonini G
Expert Rev Anticancer Ther; 2015; 15(8):971-6. PubMed ID: 26112080
[TBL] [Abstract][Full Text] [Related]
16. Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).
Muro K; Boku N; Shimada Y; Tsuji A; Sameshima S; Baba H; Satoh T; Denda T; Ina K; Nishina T; Yamaguchi K; Takiuchi H; Esaki T; Tokunaga S; Kuwano H; Komatsu Y; Watanabe M; Hyodo I; Morita S; Sugihara K
Lancet Oncol; 2010 Sep; 11(9):853-60. PubMed ID: 20708966
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
